An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma

scientific article published on 30 December 2013

An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CANLET.2013.12.030
P8608Fatcat IDrelease_j6wjqnx7yjctpmr23ifzehkzsa
P932PMC publication ID3959904
P698PubMed publication ID24384092
P5875ResearchGate publication ID259565788

P50authorRobert N. LubenQ30506463
P2093author name stringChanghui Deng
Ameae M Walker
Dunyong Tan
Jianjun Huang
KuanHui E Chen
Trina Mansour
Peizhi Tang
P2860cites workVitamin D and the mammary gland: a review on its role in normal development and breast cancerQ21195200
ASPP proteins specifically stimulate the apoptotic function of p53Q24291844
Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligaseQ24306203
Signal transducer and activator of transcription 5A/B in prostate and breast cancersQ28281791
AP-1 subunits: quarrel and harmony among siblingsQ28295184
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformationQ29400446
Investigation of transcription factor Brachyury (T) expression in human normal and tumor tissuesQ33412286
Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanismQ33658181
AP-1: one switch for many signalsQ33783550
The significance of tetramerization in promoter recruitment by Stat5.Q33957422
IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cellsQ35141573
Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.Q35683515
The two faces of Janus kinases and their respective STATs in mammary gland development and cancerQ35685851
Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expressionQ35783020
Regulation of STAT signalling by proteolytic processingQ35988016
Transcription factors control invasion: AP-1 the first among equalsQ36519045
Interleukin-3 signals through multiple isoforms of Stat5.Q36678242
Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapyQ36736714
Differential regulation of rat beta-casein-chloramphenicol acetyltransferase fusion gene expression in transgenic miceQ36765867
Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.Q36791514
The Stat family of transcription factors have diverse roles in mammary gland developmentQ37250635
Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response.Q37680260
Retinoids, retinoic acid receptors, and cancerQ37809078
Pharmacological modulation of beta-catenin and its applications in cancer therapyQ38089341
Signal transducer and activator of transcription-5 activation and breast cancer prognosisQ38447519
Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context.Q38667106
Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells.Q40481661
Inaccuracies in MTS assays: major distorting effects of medium, serum albumin, and fatty acidsQ40506756
Carboxyl-truncated STAT5beta is generated by a nucleus-associated serine protease in early hematopoietic progenitors.Q41052289
S179D prolactin primarily uses the extrinsic pathway and mitogen-activated protein kinase signaling to induce apoptosis in human endothelial cells.Q45934268
Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone.Q45957812
Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cellsQ46757934
Stat5a is mandatory for adult mammary gland development and lactogenesis.Q48055024
Identification of a novel retrovirus long terminal repeat (LTR) that is targeted by p51A (TAp63gamma) and selective dominant-negative activity of p73L (DeltaNp63alpha) toward p53-responsive promoter activitiesQ48347444
PRL activates the cyclin D1 promoter via the Jak2/Stat pathway.Q52545721
Loss of Stat5a delays mammary cancer progression in a mouse model.Q53389128
Stat5 tetramer formation is associated with leukemogenesisQ58326863
Expression of a carboxy terminally truncated Stat5 with no transactivation domain in the mammary glands of transgenic mice inhibits cell proliferation during pregnancy, delays onset of milk secretion, and induces apoptosis upon involutionQ83096020
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)148-157
P577publication date2013-12-30
P1433published inCancer LettersQ326372
P1476titleAn N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma
P478volume346

Reverse relations

cites work (P2860)
Q37344508Biomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validation
Q37000093SURVIV for survival analysis of mRNA isoform variation

Search more.